BostonSight is a nonprofit healthcare organization that advances the treatment of diseased and damaged corneas and dry eye. We work toward optimal patient outcomes through compassionate care, innovative scleral lens design, education, and technology. PROSE® is our medical treatment for the most severe or challenging ocular surface disease cases and delivered via highly trained eye care professionals at top tertiary eye centers. BostonSight SCLERAL® is our commercially available scleral lens used by optometrists worldwide. BostonSight SCLERAL provides diagnostic lens and free form fitting options with a range of diameters and features to simplify scleral lens fitting. BostonSight SCLERAL is effective for simple to more advanced ocular surface disease cases. Learn more at www.bostonsight.org and www.bostonsightscleral.org
Looking for a particular BostonSight employee's phone or email?
The BostonSight annual revenue was $5.8 million in 2026.
Gary Gut is the President and Chief Executive Officer of BostonSight.
41 people are employed at BostonSight.
BostonSight is based in Needham, Massachusetts.
The NAICS codes for BostonSight are [6213, 621320, 621, 62132, 62].
The SIC codes for BostonSight are [804, 80].